An Indian company has invested in a Cranbury-based biopharmaceutical firm, the two companies announced Wednesday.
Strides Arcolab, a global pharmaceutical company headquartered in Bangalore, India, has made a series of strategic investments in Oncobiologics Inc. which is developing a pipeline of biotherapeutics, the companies said in a news release.
"The investments by Strides Arcolab represent important milestones for Oncobiologics,” Pankaj Mohan, Oncobiologics’ founder and CEO, said in the release. “Strides Arcolab is a long-term strategic partner that provides both financial strength and a proven track record of successful business ventures. We look forward to their support and guidance as we continue to execute Oncobiologics' business and technical plans."
Terms of the investments were not disclosed.
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy